Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitey Nose: Nasal Allergen Challenge in E-cigarette Users vs Smokers
NCT03023397Phase 1Terminated
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Mar 2017
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
Phase 1, open-label trial (3 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Mean Change in Eosinophils Per mL in Nasal Lavage Fluid (NLF) and Mean Change in Eosinophilic Cationic Protein (ECP) Levels in Nasal Epithelial Lining Fluid (NELF). Started Mar 2017; status: terminated.
Beyond the preview
Go deeper on NCT03023397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03023397.